Intra-Aortic Balloon Pump Therapy
The predominant MCS device -
a trusted, valuable first-line option
IABP Therapy has been around for over 50 years.
IABP has been the first line choice for mechanical circulatory support due to its clinical efficacy, safety profile and low cost. It has been and continues to be the most widely used Mechanical Circulatory Support (MCS) device.
If you are a current user of our IAB and IABP devices, please click on the link below to find the latest product support and software update information.
Cardiogenic Shock is a complex clinical syndrome that remains a major cause of global mortality and morbidity.
Early use of intra-aortic balloon pump therapy is associated with survival benefits, regardless of etiology[1]
Acute heart failure is a potentially life-threatening condition
Early initiation of IABP may provide hemodynamic benefit as primary treatment for advanced decompensated heart failure[2]
Elevating IABP Therapy with fiber-optics and larger volume balloon catheters
Fiber-optic technology is a way to minimize the inaccuracies of a fluid-filled system. Combined with Getinge's larger volume balloon, patients receive greater systolic unloading and higher augmentation, with the potential of a greater increase in cardiac output compared to the older 40cc balloons.
Don’t Miss a Beat
When your patients are counting on you, don’t miss a beat. Count on Getinge’s Cardiosave platform as your first line of mechanical circulatory support
Explore our products
Find the right products and solutions for you
IAB and IABP product info and update center
Stay up-to-date on Getinge IAB and IABP reference materials.
- Quick reference guides
- Clinical considerations
- Instructional videos
- Training presentations